Citations

Mayo Clinic

Clear

453 citation(s) found for "Family, and".

Genomic Organization and Expression Analysis of B7-H4, an Immune Inhibitory Molecule of the B7 Family
Choi, In-Hak, Zhu, Gefeng, Sica, Gabriel , Strome, Scott E. , Cheville, John C. , Lau, Julie S., Zhu, Yuwen , Flies, Dallas B. , Tamada, Koji , Chen, Lieping

The Journal of Immunology | April 20, 2014 | Volume: 171 | Issue: 9 | Pages: 4650-4654

10.4049/jimmunol.171.9.4650 | PMID 14568939 Get It

Abstract B7-H4 is a recently identified B7 family member that negatively regulates T cell immunity by the inhibition of T cell proliferation, cytokine production, and cell cycle progression. In this study, we report that the genomic DNA of human B7-H4 is mapped on chromosome 1 comprised of six exons and five introns spanning 66 kb, of which exon 6 is used for alternative splicing to generate two different transcripts. Similar B7-H4 structure is also found in mouse genomic DNA in chromosome 3. A human B7-H4 pseudogene is identified in chromosome 20p11.1 with a single exon and two stop codons in the coding region. Immunohistochemistry analysis using B7-H4-specific mAb demonstrates that B7-H4 is not expressed on the majority of normal human tissues. In contrast, up to 85% (22 of 26) of ovarian cancer and 31% (5 of 16) of lung cancer tissues constitutively express B7-H4. Our results indicate a tight regulation of B7-H4 expression in the translational level in normal peripheral tissues and a potential role of B7-H4 in the evasion of tumor immunity.
A Randomized Trial to Increase Colonoscopy Screening in Members of High-Risk Families in the Colorectal Cancer Family Registry and Cancer Genetics Network
Lowery, Jan T. , Horick, Nora , Kinney, Anita Y. , Garrett, Kathleen, Haile, Robert W. , Lindor, Noralane M. , Sandler, Robert S. , Burke, Carol A. , Hill, Deirdre A. , Ahnen, Dennis J. , Finkelstein, Dianne M. , Newcomb, Polly A. , Haile, Robert W , Sandler, Robert S , Burke, Carol A , Horick, Nora

Cancer Epidemiology, Biomarkers & Prevention | February 5, 2014 | Volume: 23 | Issue: 4 | Pages: 601-610

10.1158/1055-9965.epi-13-1085 | PMID 24501379 Get It

Abstract Background: Individuals with a strong family history of colorectal cancer have significant risk for colorectal cancer, although adherence to colonoscopy screening in these groups remains low. This study assessed whether a tailored telephone counseling intervention can increase adherence to colonoscopy in members of high-risk families in a randomized, controlled trial. Methods: Eligible participants were recruited from two national cancer registries if they had a first-degree relative with colorectal cancer under age 60 or multiple affected family members, which included families that met the Amsterdam criteria for hereditary non-polyposis colon cancer (HNPCC), and if they were due for colonoscopy within 24 months. Participants were randomized to receive a tailored telephone intervention grounded in behavioral theory or a mailed packet with general information about screening. Colonoscopy status was assessed through follow-up surveys and endoscopy reports. Cox proportional hazards models were used to assess intervention effect. Results: Of the 632 participants (ages 25–80), 60% were female, the majority were White, non-Hispanic, educated, and had health insurance. Colonoscopy adherence increased 11 percentage points in the tailored telephone intervention group, compared with no significant change in the mailed group. The telephone intervention was associated with a 32% increase in screening adherence compared with the mailed intervention (HR, 1.32; P = 0.01). Conclusions: A tailored telephone intervention can effectively increase colonoscopy adherence in high-risk persons. This intervention has the potential for broad dissemination to healthcare organizations or other high-risk populations. Impact: Increasing adherence to colonoscopy among persons with increased colorectal cancer risk could effectively reduce incidence and mortality from this disease. Cancer Epidemiol Biomarkers Prev; 23(4); 601–10. ©2014 AACR.
American Society of Clinical Oncology Expert Statement: Collection and Use of a Cancer Family History for Oncology Providers
Lu, Karen H. , Wood, Marie , Daniels, Molly S. , Burke, Cathy, Ford, James M. , Kauff, Noah D. , Kohlmann, Wendy , Lindor, Noralane M. , Mulvey, Therese M. , Robinson, Linda, Rubinstein, Wendy S. , Snyder, Carrie, Merrill, Janette K. , Wollins, Dana S., Hughes, Kevin S. , Stoffel, Elena M. , Syngal, Sapna , Hughes, Kevin

Journal of Clinical Oncology | February 4, 2014 | Volume: 32 | Issue: 8 | Pages: 833-840

10.1200/jco.2013.50.9257 | PMID 24493721 Get It

Exome Sequencing Identifies a Novel FOXP3 Mutation in a 2‐Generation Family With Inflammatory Bowel Disease
Okou, David T. , Mondal, Kajari , Faubion, William A. , Kobrynski, Lisa , Denson, Lee A. , Mullé, Jennifer G. , Xiong, Yuning, Svingen, Phyllis A., Bose, Promita, Waters, Jon, Cutler, David J. , Ramachandran, Dhanya , Patel, Viren , Prahalad, Sampath , Zwick, Michael E. , Kugathasan, Subra

Journal of Pediatric Gastroenterology and Nutrition | January 14, 2014 | Volume: 58 | Issue: 5 | Pages: 561-568

10.1097/mpg.0000000000000302 | PMID 24792626 Get It

ABSTRACTObjectives:Inflammatory bowel disease (IBD) is heritable, but a total of 163 variants commonly implicated in IBD pathogenesis account for only 25% of the heritability. Rare, highly penetrant genetic variants may also explain mendelian forms of IBD and some of the missing heritability. To test the hypothesis that rare loss‐of‐function mutations can be causative, we performed whole exome sequencing (WES) on 5 members of a 2‐generation family of European ancestry presenting with an early‐onset and atypical form of IBD.Methods:WES was performed for all of the 5 family members; the mother and 3 male offspring were affected, whereas the father was unaffected. Mapping, annotation, and filtering criteria were used to reduce candidate variants. For functional testing we performed forkhead box P3 (FOXP3) staining and a T‐cell suppression assay.Results:We identified a novel missense variant in exon 6 of the X‐linked FOXP3 gene. The c.694A>C substitution in FOXP3 results in a cysteine‐to‐glycine change at the protein position 232 that is completely conserved among all vertebrates. This variant (heterozygous in the mother and hemizygous in all 3 affected sons) did not impair FOXP3 protein expression, but significantly reduced the ability of the host's T regulatory cells to suppress an inappropriate autoimmune response. The variant results in a milder immune dysregulation, polyendocrinopathy, enteropathy, and X‐linked phenotype with early‐onset IBD.Conclusions:Our study illustrates the successful application of WES for making a definitive molecular diagnosis in a case of multiply affected families, with atypical IBD‐like phenotype. Our results also have important implications for disease biology and disease‐directed therapeutic development.
Using Item Response Theory to Model Multiple Phenotypes and Their Joint Heritability in Family Data
Fragoso, Tiago M., Giolo, Suely Ruiz , Pereira, Alexandre C. , Andrade, Mariza de , Soler, Júlia Maria Pavan , de Andrade, Mariza

Genetic Epidemiology | January 12, 2014 | Volume: 38 | Issue: 2 | Pages: 152-161

10.1002/gepi.21784 | PMID 24415554 Get It

ABSTRACTMany important complex diseases are composed of a series of phenotypes, which makes the disease diagnosis and its genetic dissection difficult. The standard procedures to determine heritability in such complex diseases are either applied for single phenotype analyses or to compare findings across phenotypes or multidimensional reduction procedures, such as principal components analysis using all phenotypes. However each method has its own problems and the challenges are even more complex for extended family data and categorical phenotypes. In this paper, we propose a methodology to determine a scale for complex outcomes involving multiple categorical phenotypes in extended pedigrees using item response theory (IRT) models that take all categorical phenotypes into account, allowing informative comparison among individuals. An advantage of the IRT framework is that a straightforward joint heritability parameter can be estimated for categorical phenotypes. Furthermore, our methodology allows many possible extensions such as the inclusion of covariates and multiple variance components. We use Markov Chain Monte Carlo algorithm for the parameter estimation and validate our method through simulated data. As an application we consider the metabolic syndrome as the multiple phenotype disease using data from the Baependi Heart Study consisting of 1,696 individuals in 95 families. We adjust IRT models without covariates and include age and age squared as covariates. The results showed that adjusting for covariates yields a higher joint heritability () than without co variates () indicating that the covariates absorbed some of the error variance.
Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease
Benzinger, Tammie L.S. , Blazey, Tyler , Xiong, Chengjie , Raichle, Marcus E. , Ances, Beau M. , Bateman, Randall J. , Cairns, Nigel J., Fagan, Anne M. , Goate, Alison , Marcus, Daniel S. , Aisen, Paul, Christensen, Jon, Ercole, Lindsay, Hornbeck, Russ C. , Farrar, Angela, Aldea, Patricia, Jasielec, Mateusz S., Owen, Christopher J. , Xie, Xianyun, Mayeux, Richard , Klunk, William E. , Mathis, Chester A. , Ringman, John M. , Thompson, Paul M. , Saykin, Andrew J. , Johnson, Keith A. , Salloway, Stephen , Correia, Stephen , Schofield, Peter R. , Masters, Colin L. , Villemagne, Victor L. , Martins, Ralph N. , Ourselin, Sébastien , Rossor, Martin N. , Fox, Nick C. , Cash, David M. , Weiner, Michael W. , Buckles, Virginia, Moulder, Krista L., Morris, John C. , Jack, Clifford R. , Koeppe, Robert A. , Su, Yi , Xiong, Chengjie , Snyder, Abraham Z. , Brickman, Adam M. , McDade, Eric , Ghetti, Bernardino , Sperling, Reisa Anne , Rowe, Christopher Cleon , Holtzman, David M. , Saykin, Andrew J , Schofield, Peter R , Thompson, Paul M , Bateman, Randall J , Masters, Colin L , Benzinger, Tammie L S , Ances, Beau M , Fox, Nick C , Morris, John C , Cash, David M , Goate, Alison M

Proceedings of the National Academy of Sciences | November 5, 2013 | Volume: 110 | Issue: 47 | Pages: No page available

10.1073/pnas.1317918110 | PMID 24194552 Get It

Significance Beta-amyloid plaque accumulation, glucose hypometabolism, and neuronal atrophy are hallmarks of Alzheimer’s disease. However, the regional ordering of these biomarkers prior to dementia remains untested. In a cohort with Alzheimer’s disease mutations, we performed an integrated whole-brain analysis of three major imaging techniques: amyloid PET, [ 18 F]fluro-deoxyglucose PET, and structural MRI. We found that most gray-matter structures with amyloid plaques later have hypometabolism followed by atrophy. Critically, however, not all regions lose metabolic function, and not all regions atrophy, even when there is significant amyloid deposition. These regional disparities have important implications for clinical trials of disease-modifying therapies.
Use of Antidepressant Medication in the United States During Pregnancy, 2002–2010
Meunier, Matthew R. , Bennett, Ian M. , Coco, Andrew

Psychiatric Services | November 1, 2013 | Volume: 64 | Issue: 11 | Pages: 1157-1160

10.1176/appi.ps.201200455 | PMID 24185537 Get It

P1–282: Effect of APOE and family history of dementia on Alzheimer's disease imaging biomarkers in cognitively normal subjects
Wiste, Heather J. , Weigand, Stephen D. , Lowe, Val J. , Petersen, Ronald C. , Vemuri, Prashanthi , Knopman, David S. , Mielke, Michelle M. , Machulda, Mary M. , Jack, Clifford R.

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_6 | Pages: No page available

10.1016/j.jalz.2013.05.507 Get It

IC‐P‐136: Effect of APOE and family history of dementia on Alzheimer's imaging biomarkers in cognitively normal individuals
Wiste, Heather J. , Weigand, Stephen D. , Lowe, Val J. , Petersen, Ronald C. , Vemuri, Prashanthi , Knopman, David S. , Mielke, Michelle M. , Machulda, Mary M. , Jack, Clifford R.

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_2 | Pages: No page available

10.1016/j.jalz.2013.05.133 Get It